SCHEMBL7790315

SCHEMBL7790315

CC(C)N(O)c1ccc(C(N)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 9/20 0.48
CA2 P00918 3/20 0.44
PARP4 Q9UKK3 2/20 0.44
PARP1 P09874 2/20 0.44
CA1 P00915 2/20 0.44
PARP2 Q9UGN5 1/20 0.44
ALDH1A1 P00352 2/20 0.42
PARP15 Q460N3 2/20 0.42
KMT2A Q03164 1/20 0.42
PARP14 Q460N5 1/20 0.42
PARP16 Q8N5Y8 1/20 0.42
PARP11 Q9NR21 1/20 0.42
HSD17B10 Q99714 2/20 0.41
TSHR P16473 2/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1128718 0.82 PARP10 (0.50) PARP10CA2PARP4PARP1CA1
SCHEMBL2852148 0.76 MAPT (0.49) PARP10CA2PARP4PARP1CA1
Hydrochloric Acid SCHEMBL4867978 0.74 MAPT (0.48) PARP10CA2PARP4PARP1CA1
SCHEMBL632045 0.74 ALDH1A1 (0.67) PARP10CA2PARP4PARP1CA1
SCHEMBL2882577 0.73 NPSR1 (0.54) PARP10CA2PARP4PARP1CA1
SCHEMBL20919357 0.73 PARP1 (0.52) PARP10CA2PARP4PARP1CA1
SCHEMBL10440811 0.73 HPGD (0.44) ALDH1A1KMT2ATSHRMAPTCYP3A4
Terephthalamide SCHEMBL27683041 0.73 PARP10 (0.58) PARP10CA2PARP4PARP1CA1
SCHEMBL16168831 0.72 PARP10 (0.48) PARP10CA2PARP4PARP1CA1
Terephthalamide SCHEMBL23774 0.72 PARP1 (0.71) PARP10CA2PARP4PARP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010014683-A1 Analgesics; side effect reduction ITO FUMITAKA (JP) 2001-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014683-A1 Analgesics; side effect reduction OPRL1, OPRK1, OPRD1 PARP10 835/4885CA2 1184/4885PARP4 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.